Natixis Advisors, L.P. Danaher Corp Transaction History

Natixis Advisors, L.P.

$51.3 Billion
Q3 2024

A detailed history of Natixis Advisors, L.P. transactions in Danaher Corp stock. As of the latest transaction made, Natixis Advisors, L.P. holds 802,429 shares of DHR stock, worth $187 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares

802,429

Previous 763,400 5.11%

Holding current value

$187 Million

Previous $191 Million 16.96%

% of portfolio

0.44%

Previous 0.41%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$239.25 - $280.76 $9.34 Million - $11 Million	39,029 Added 5.11%	802,429 $223 Million
Q2 2024 Aug 01, 2024	BUY	$235.51 - $267.98 $849,484 - $966,603	3,607 Added 0.47%	763,400 $191 Million
Q1 2024 Apr 25, 2024	BUY	$224.58 - $256.19 $33.6 Million - $38.3 Million	149,481 Added 24.49%	759,793 $190 Million
Q4 2023 Feb 06, 2024	BUY	$185.1 - $233.13 $4.84 Million - $6.1 Million	26,147 Added 4.48%	610,312 $141 Million
Q3 2023 Nov 13, 2023	BUY	$233.08 - $265.59 $30.2 Million - $34.4 Million	129,699 Added 28.54%	584,165 $128 Million
Q2 2023 Aug 15, 2023	SELL	$224.99 - $256.14 $20.8 Million - $23.6 Million	-92,307 Reduced 16.88%	454,466 $109 Million
Q1 2023 May 11, 2023	BUY	$239.75 - $277.0 $12.9 Million - $14.9 Million	53,873 Added 10.93%	546,773 $138 Million
Q4 2022 Jan 27, 2023	SELL	$241.42 - $282.29 $10.9 Million - $12.8 Million	-45,214 Reduced 8.4%	492,900 $131 Million
Q3 2022 Nov 14, 2022	BUY	$247.06 - $1507.4 $24 Million - $146 Million	97,152 Added 22.03%	538,114 $139 Million
Q2 2022 Aug 12, 2022	SELL	$237.11 - $299.66 $15.1 Million - $19.1 Million	-63,742 Reduced 12.63%	440,962 $112 Million
Q1 2022 May 12, 2022	BUY	$257.27 - $315.76 $6.72 Million - $8.25 Million	26,129 Added 5.46%	504,704 $148 Million
Q4 2021 Feb 08, 2022	BUY	$292.08 - $329.01 $24.6 Million - $27.7 Million	84,153 Added 21.34%	478,575 $157 Million
Q3 2021 Nov 15, 2021	BUY	$272.21 - $332.43 $48 Million - $58.6 Million	176,320 Added 80.84%	394,422 $120 Million
Q2 2021 Aug 12, 2021	BUY	$225.08 - $271.69 $2.76 Million - $3.33 Million	12,248 Added 5.95%	218,102 $58.5 Million
Q1 2021 May 05, 2021	BUY	$212.38 - $245.9 $1.83 Million - $2.12 Million	8,620 Added 4.37%	205,854 $46.3 Million
Q4 2020 Feb 12, 2021	BUY	$212.5 - $245.46 $215,900 - $249,387	1,016 Added 0.52%	197,234 $43.8 Million
Q3 2020 Nov 12, 2020	SELL	$177.16 - $215.33 $3.07 Million - $3.73 Million	-17,336 Reduced 8.12%	196,218 $42.3 Million
Q2 2020 Aug 11, 2020	BUY	$128.7 - $176.83 $2.66 Million - $3.66 Million	20,698 Added 10.73%	213,554 $37.8 Million
Q1 2020 Apr 27, 2020	SELL	$121.39 - $169.05 $2.06 Million - $2.87 Million	-16,997 Reduced 8.1%	192,856 $26.7 Million
Q4 2019 Feb 10, 2020	BUY	$133.47 - $153.48 $1.61 Million - $1.85 Million	12,039 Added 6.09%	209,853 $32.2 Million
Q3 2019 Nov 12, 2019	BUY	$135.4 - $146.47 $2.14 Million - $2.32 Million	15,819 Added 8.69%	197,814 $28.6 Million
Q2 2019 Aug 12, 2019	BUY	$124.88 - $143.73 $560,586 - $645,203	4,489 Added 2.53%	181,995 $26 Million
Q1 2019 May 15, 2019	SELL	$97.62 - $132.29 $1.34 Million - $1.82 Million	-13,727 Reduced 7.18%	177,506 $23.4 Million
Q4 2018 Feb 13, 2019	SELL	$94.85 - $109.54 $83,278 - $96,176	-878 Reduced 0.46%	191,233 $19.7 Million
Q3 2018 Nov 13, 2018	BUY	$98.13 - $108.9 $258,081 - $286,407	2,630 Added 1.39%	192,111 $20.9 Million
Q2 2018 Aug 14, 2018	BUY	$96.1 - $103.24 $832,898 - $894,781	8,667 Added 4.79%	189,481 $0
Q1 2018 May 10, 2018	BUY	$92.16 - $103.8 $1.36 Million - $1.53 Million	14,744 Added 8.88%	180,814 $17.7 Million
Q4 2017 Feb 14, 2018	BUY	$85.26 - $94.62 $245,037 - $271,937	2,874 Added 1.76%	166,070 $15.4 Million
Q3 2017 Nov 14, 2017	BUY	$79.29 - $88.45 $12.9 Million - $14.4 Million	163,196	163,196 $14 Million

Others Institutions Holding DHR

# of Institutions

2,507

Shares Held

542M

Call Options Held

7.07M

Put Options Held

4.55M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $170B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.

Account

Natixis Advisors, L.P. Danaher Corp Transaction History